HYOU1 Antikörper (Center)
Kurzübersicht für HYOU1 Antikörper (Center) (ABIN2287111)
Target
Alle HYOU1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 281-311, Center
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- Hypoxia Up-regulated Protein 1 (HYOU1, 150kD Oxygen-regulated Protein, ORP150, ORP-150, 170kD Glucose-regulated Protein, Grp170, GRP-170, DKFZp686N08236, FLJ94899, FLJ97572, HSP12A)
-
Aufreinigung
- Purified by ammonium sulfate precipitation.
-
Immunogen
- Synthetic peptide between corresponding to a portion of amino acids within aa281-311 selected from the Center region of human HYOU1 conjugated to KLH.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- HYOU1 (Hypoxia Up Regulated 1 (HYOU1))
-
Andere Bezeichnung
- Hypoxia Up-Regulated Protein 1
-
NCBI Accession
- NP_006380
-
UniProt
- Q9Y4L1
-
Pathways
- ER-Nucleus Signaling, SARS-CoV-2 Protein Interaktom
Target
-